Selank Peptide Causes Changes in Gene Expression in the Hippocampus of Rats in the Early Hours after Acute Restraint Stress

Stress is a risk factor for the development of anxiety-depressive disorders, cardiovascular diseases, and cognitive impairment. The peptide drug ThrLysProArgProGlyPro (Selank), an analogue of endogenous tuftsin, has entered clinical practice as an anxiolytic agent acting as a positive allosteric mod...

Ausführliche Beschreibung